Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) EBT Margin (2023 - 2025)

Upstream Bio (UPB) has 2 years of EBT Margin data on record, last reported at 5310.54% in Q3 2025.

  • For Q3 2025, EBT Margin fell 231746.0% year-over-year to 5310.54%; the TTM value through Sep 2025 reached 4911.0%, changed N/A, while the annual FY2024 figure was 3047.3%, 153684.0% down from the prior year.
  • EBT Margin reached 5310.54% in Q3 2025 per UPB's latest filing, roughly flat from 5327.21% in the prior quarter.
  • Across five years, EBT Margin topped out at 2147.97% in Q1 2024 and bottomed at 5327.21% in Q2 2025.